Location History:
- Suffern, NY (US) (2013 - 2015)
- Suffren, NY (US) (2017)
Company Filing History:
Years Active: 2013-2017
Title: Jasdeep Singh Nanra: Innovator in Immunogenic Conjugates
Introduction
Jasdeep Singh Nanra is a notable inventor based in Suffern, NY (US). He has made significant contributions to the field of immunogenic conjugates, holding a total of 5 patents. His work focuses on the development of innovative methods for preparing immunogenic conjugates that can enhance vaccine efficacy.
Latest Patents
Among his latest patents, Jasdeep has developed immunogenic conjugates that comprise serotype 5 and 8 capsular polysaccharides conjugated to carrier proteins. The methods for creating these conjugates involve covalent conjugation of the capsular polysaccharides with carrier proteins using advanced conjugation chemistry techniques. These techniques include the use of 1,1-carbonyl-di-1,2,4-triazole (CDT) and 3-(2-pyridyldithio)-propionyl hydrazide (PDPH).
Career Highlights
Jasdeep Singh Nanra is currently associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on groundbreaking research in immunology and vaccine development.
Collaborations
Throughout his career, Jasdeep has collaborated with esteemed colleagues, including Annaliesa Sybil Anderson and Viliam Pavliak. These collaborations have further enriched his research and contributed to the advancement of immunogenic conjugate technologies.
Conclusion
Jasdeep Singh Nanra's innovative work in the field of immunogenic conjugates exemplifies the impact of dedicated research on vaccine development. His contributions continue to pave the way for advancements in immunology and public health.